Related Experiment Video
Updated: Aug 6, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Integrated pregnancy and perinatal management of complex fetal congenital heart disease: a preliminary retrospective
Xie Junshu1, Yin Fufen1, Yin Xiuju1
1Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, 100044, China.
Insights
Integrated management of complex congenital heart disease (CHD) in fetuses resulted in favorable outcomes. Delivery timing and mode should be individualized, with prostaglandin use improving neonatal oxygen saturation and surgical interventions yielding high success rates.
Area of Science:
- Perinatology
- Pediatric Cardiology
- Fetal Medicine
Background:
- Congenital heart disease (CHD) is the leading cause of neonatal mortality globally.
- Optimal management strategies for fetuses with complex CHD remain uncertain for obstetricians in China.
Purpose of the Study:
- To investigate integrated pregnancy and perinatal management for fetuses diagnosed with complex CHD via prenatal ultrasound in China.
Main Methods:
- Retrospective analysis of 123 fetuses with complex CHD diagnosed by prenatal ultrasound (2016-2023).
- Evaluation of delivery timing, mode, genetic testing, postnatal interventions, and surgical outcomes.
Main Results:
- Most common diagnosis was complete transposition of the great arteries (D-TGA) (56.1%).
- Cesarean delivery rate was 62.6%; mean gestational age at delivery was 37.9 weeks.
- Prostaglandin improved oxygen saturation (72.8% to 80.5%); 98.2% of 114 neonates had favorable surgical outcomes.
Conclusions:
- Avoid preterm birth for fetuses with complex CHD; delivery mode should be based on obstetric factors.
- Consider delivery at or beyond 39 weeks if maternal and fetal status are stable.
- Prostaglandin and coordinated multidisciplinary care are crucial for favorable outcomes in complex fetal CHD.
Background:
Congenital heart disease (CHD) is the most prevalent congenital abnormality worldwide and is the primary contributor to neonatal mortality. Obstetricians in China continue to face uncertainties about optimal delivery timing, appropriate delivery mode, perinatal interventions, and postnatal surgical outcomes for fetuses with complex CHD.
Objective:
To investigate integrated pregnancy and perinatal management strategies for fetuses diagnosed with complex CHD by prenatal ultrasound in China.
Methods:
A retrospective analysis was performed on 123 fetuses with complex CHD diagnosed by prenatal ultrasound at Peking University People's Hospital between 2016 and 2023.
Results:
The mean gestational age at ultrasound diagnosis was 23.7 ± 3.4 weeks. Among the 123 cases, 11 (8.9%) were total anomalous pulmonary venous connection (TAPVC), 14 (11.4%) pulmonary valve abnormalities (PVA), 7 (5.7%) right ventricular double outlet (DORV), 13 (10.6%) aortic arch abnormalities, 69 (56.1%) complete transposition of the great arteries (D-TGA), and 9 (7.3%) other types. Following prenatal counseling, all pregnancies were continued. Among the 72 fetuses undergoing prenatal genetic testing, 9 (9/72) showed chromosomal variants. Fifty-five pregnant women (44.72%) attempted trial of labor, of whom 46 (37.40%) achieved vaginal delivery, including 6 (4.88%) assisted with forceps. Trial of labor failed in 9 cases, requiring cesarean section. In total, 77 pregnancies were delivered by cesarean section, yielding a cesarean rate of 62.6%. The mean gestational age at delivery was 37.9 ± 1.4 weeks, and the mean neonatal birth weight was 3099.0 ± 479.6 g. The mean umbilical arterial blood gas pH was 7.31 ± 0.05. Postnatally, 86 infants (69.9%) received prostaglandin. Average oxygen saturation increased from 72.8 ± 6.0% before alprostadil administration to 80.5 ± 5.0% afterward, a statistically significant improvement (p = 0.000). A total of 114 neonates underwent surgical intervention; 98.2% achieved favorable outcomes, whereas two infants (1.8%) died postoperatively. Approximately 13.0% were anticipated to require secondary surgery.
Conclusion:
Pregnancies involving fetuses with complex CHD should avoid preterm birth whenever possible. Complex fetal CHD alone is not an indication for cesarean delivery; the delivery mode should instead be determined by standard obstetric considerations, and individualized management may be adopted according to their opinions and preferences. When both maternal and fetal status remain stable, scheduling delivery at or beyond 39 weeks may be considered. Newborns who present with low postnatal oxygen saturation should receive prostaglandin to keep the ductus arteriosus open, followed by urgent transfer to pediatric cardiac surgery for definitive management. Coordinated, multidisciplinary care supports favorable clinical outcomes.
Related Concept Videos
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Mitral Valve Prolapse II: Assessment and Management
